Martine Rothblatt's Common Stock Sales in United Therapeutics Corp

Martine Rothblatt, the Founder, Chairperson, and CEO of United Therapeutics Corp, has filed a notice of sale of common stock. The filing details the sale of 4,000 shares on October 28, 2025, with an aggregate market value of $1,661,555.20. Additionally, the filing includes a comprehensive list of sales transactions over the past three months, totaling 116,000 shares sold. These transactions were executed through TD Securities (USA) LLC on the NASDAQ exchange. The securities were acquired through an Executive Deferred Compensation plan, with the initial acquisition date being March 15, 2016. The filing also notes that there are 45,230,000 common shares outstanding.